What does Remedium Capital Partners, LLC hold? Q1 2026 13F Holdings & Portfolio

AI Analysis · Q1 2026 · Q1 2026

Remedium Capital Partners, LLC filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight

Oruka Therapeutics Inc

$77M1.6M27.3%

Spyre Therapeutics Inc

$73M1.5M26.1%

Damora Therapeutics Inc

$53M2.0M18.8%

Apogee Therapeutics Inc

$49M584K17.5%

Jade Biosciences Inc

$22M1.6M7.9%

Crescent Biopharma Inc

$7M361K2.4%

Filing history loading…